Ligand Pharmaceuticals Incorporated (25) | Intellectual Property (2)
- Commercial License Agreement between Taurus Biosciences, LLC and Minotaur Therapeutics, Inc., dated September 9, 2020 (Filed With SEC on September 10, 2020)
- Addendum, dated May 22, 2019, by and among Ligand Pharmaceuticals Incorporated, CyDex Pharmaceuticals, Inc. and Acrotech Biopharma LLC (as successor-in-interest to Spectrum... (Filed With SEC on August 8, 2019)